[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Citations 0
News From the Food and Drug Administration
December 6, 2000

Drug Product Problem Reports

Author Affiliations

Not Available

Not Available

JAMA. 2000;284(21):2711. doi:10.1001/jama.284.21.2711-JFD00010-4-1

The US Pharmacopeia (USP) has ceased operating its Drug Product Problem Reporting Program, which enabled pharmacists and other health care professionals to report drug quality problems "so that its efforts an resources may be concentrated on medication error reporting and prevention." The FDA wishes to encourage those who used the USP program to report product quality problems as well as adverse medical events to MEDWATCH by phone ([800] FDA-1088), fax ([800] FDA-0178), mail (MEDWATCH, FDA, HF-2, 5600 Fishers Ln, Rockville, MD 20857), or online (http://www.accessdata.fda.gov/scripts/medwatch).

Written Inquiries may be directed to Jane E. Henney, MD, Commissioner of Food and Drugs, HF-1, Room 14-71, 5600 Fishers Ln, Rockville, MD 20857.